Roche Holding AG (RHHBY)

Revenue

Financials in millions CHF. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Roche Pharmaceuticals Revenue	44.50B	44.79B	43.30B
Chugai Revenue	2.82B	2.88B	2.87B
Pharmaceuticals Revenue	47.31B	47.67B	46.17B
Diagnostics Revenue	13.62B	13.85B	14.32B
Revenue (Other)	2.02B	1.84B	1.90B
Revenue (Total)	62.96B	63.36B	62.40B

Revenue by Geography

Financials in millions CHF. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Switzerland Revenue	-	819.00M	747.00M
Germany Revenue	-	3.12B	2.93B
Rest of Europe Revenue	-	10.86B	10.29B
Europe Revenue	-	14.80B	13.97B
United States Revenue	-	29.50B	28.90B
Rest of North America Revenue	-	972.00M	889.00M
North America Revenue	-	30.48B	29.79B
Latin America Revenue	-	3.25B	3.25B
Japan Revenue	-	3.04B	3.15B
Rest of Asia Revenue	-	8.60B	9.09B
Asia Revenue	-	11.63B	12.24B
Africa, Australia and Oceania Revenue	-	1.36B	1.25B
Revenue (Total)	62.96B	63.36B	62.40B

EBIT

Financials in millions CHF. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Roche Pharmaceuticals Operating Profit	18.15B	18.64B	12.34B
Chugai Operating Profit	3.34B	3.23B	3.21B
Pharmaceuticals Operating Profit	20.87B	21.67B	15.59B
Diagnostics Operating Profit	1.22B	1.07B	1.95B
Corporate Operating Profit	-4.28B	-4.26B	-4.12B
Operating Income (Total)	17.82B	18.48B	13.42B

Capital Expenditures

Financials in millions CHF. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Roche Pharmaceuticals Capital Expenditures	5.37B	6.68B	6.00B
Chugai Capital Expenditures	523.00M	595.00M	350.00M
Pharmaceuticals Capital Expenditures	5.90B	7.27B	6.35B
Diagnostics Capital Expenditures	2.63B	2.20B	2.44B
Corporate Capital Expenditures	61.00M	53.00M	78.00M

Data Source: Fiscal.ai Last updated: Jun 30, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 24, 2026

Data Sources Report a data error